AU1384799A - Novel igf-i composition and its use - Google Patents

Novel igf-i composition and its use

Info

Publication number
AU1384799A
AU1384799A AU13847/99A AU1384799A AU1384799A AU 1384799 A AU1384799 A AU 1384799A AU 13847/99 A AU13847/99 A AU 13847/99A AU 1384799 A AU1384799 A AU 1384799A AU 1384799 A AU1384799 A AU 1384799A
Authority
AU
Australia
Prior art keywords
composition
novel igf
igf
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13847/99A
Inventor
Maninder S. Hora
Bret A. Shirley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of AU1384799A publication Critical patent/AU1384799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AU13847/99A 1997-11-07 1998-11-06 Novel igf-i composition and its use Abandoned AU1384799A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6489197P 1997-11-07 1997-11-07
US60064891 1997-11-07
US9608198P 1998-08-11 1998-08-11
US60096081 1998-08-11
PCT/US1998/023672 WO1999024062A1 (en) 1997-11-07 1998-11-06 Novel igf-i composition and its use

Publications (1)

Publication Number Publication Date
AU1384799A true AU1384799A (en) 1999-05-31

Family

ID=26745004

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13847/99A Abandoned AU1384799A (en) 1997-11-07 1998-11-06 Novel igf-i composition and its use

Country Status (4)

Country Link
EP (1) EP1028747A1 (en)
JP (1) JP2001522813A (en)
AU (1) AU1384799A (en)
WO (1) WO1999024062A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573238B2 (en) 1997-11-07 2003-06-03 Chiron Corporation Method for producing sustained-release formulations
JP2002510646A (en) * 1998-04-03 2002-04-09 カイロン コーポレイション Use of IGFI for treating articular cartilage disorders
AUPQ729000A0 (en) * 2000-05-03 2000-05-25 Gropep Limited Treatment of damaged connective tissue
BR0113626A (en) 2000-08-30 2003-06-17 Pfizer Prod Inc Sustained-Release Formulations for Growth Hormone Secretors
WO2008035230A2 (en) * 2006-09-18 2008-03-27 Novozymes Gropep Limited Liquid compositions comprising substantially purified igf at or below ph 5.0
CN102665691B (en) 2009-11-17 2015-05-27 益普生制药股份有限公司 Formulation for hGH and rhIGF-1 combination
US20110152188A1 (en) * 2009-12-23 2011-06-23 Hanns-Christian Mahler Pharmaceutical compositions of igf/i proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297860B1 (en) * 1987-07-01 1993-09-01 Genentech, Inc. Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
JPH0818999B2 (en) * 1990-01-05 1996-02-28 藤沢薬品工業株式会社 Insulin-like growth factor I dry formulation

Also Published As

Publication number Publication date
JP2001522813A (en) 2001-11-20
EP1028747A1 (en) 2000-08-23
WO1999024062A1 (en) 1999-05-20

Similar Documents

Publication Publication Date Title
AU7219798A (en) Adhesive composition
ZA985096B (en) Composition compound and use
PL347357A1 (en) Novel composition and use
AU9781998A (en) Huchordin and uses thereof
GB9717598D0 (en) Novel composition and use
AU5335798A (en) Stomatic composition
AU1403501A (en) Novel composition and use
AU8747498A (en) Food-preservative composition
AU7659998A (en) N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
EP1002847B8 (en) Self-adhesive composition
AU8121998A (en) Composition
AU8695298A (en) Compounds and uses thereof
AU1384799A (en) Novel igf-i composition and its use
GB2328103B (en) Display composition technique
AU1098499A (en) Emulsifier-lipid composition
GB9718636D0 (en) Novel composition and use
AU1046799A (en) Compound, composition and use
AU7681498A (en) Pharmaceutical composition and use thereof
AUPO982097A0 (en) Methods and compositions for use therein
AU691690B2 (en) Acrolein-releasing composition and use thereof
AU7230398A (en) Adhesive composition
AU8693198A (en) Compounds and uses thereof
AU6128398A (en) New composition
GB2327425B (en) Adhesive composition
AU1046299A (en) Compound, composition and use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase